Informal Request for ATI Records Previously Released

Organization: Health Canada

Year: 2023

Month: August

Request Number: A-2022-001252

Request Summary: Adverse Drug Reactions (ADRs) for VEDOLIZUMAB. Report numbers: E2B_05801639, E2B_05868878, E2B_05823260. ADRs for C1 ESTERASE INHIBITOR. Report numbers: E2B_05801639, E2B_05868878, E2B_05823260.

Disposition: Disclosed in part

Number of pages: 126

Date modified: